SynBiotic SE is a Germany-based investment company. Mainly the Company invests in cannabinoid focused ventures and teams..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 3.2K |
| Three Month Average Volume | 189.1K |
| High Low | |
| Fifty-Two Week High | 19.5 EUR |
| Fifty-Two Week Low | 2.86 EUR |
| Fifty-Two Week High Date | 23 Feb 2024 |
| Fifty-Two Week Low Date | 05 Dec 2023 |
| Price and Volume | |
| Current Price | 5.96 EUR |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -13.35% |
| Thirteen Week Relative Price Change | -29.42% |
| Twenty-Six Week Relative Price Change | -39.90% |
| Fifty-Two Week Relative Price Change | -12.81% |
| Year-to-Date Relative Price Change | 78.78% |
| Price Change | |
| One Day Price Change | -2.61% |
| Thirteen Week Price Change | -28.19% |
| Twenty-Six Week Price Change | -35.78% |
| Five Day Price Change | -5.40% |
| Fifty-Two Week Price Change | 4.20% |
| Year-to-Date Price Change | 102.03% |
| Month-to-Date Price Change | -2.61% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 3.0689 EUR |
| Book Value Per Share (Most Recent Quarter) | 12.74551 EUR |
| Tangible Book Value Per Share (Last Fiscal Year) | -1.39483 EUR |
| Tangible Book Value Per Share (Most Recent Quarter) | 12.17191 EUR |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.53116 EUR |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.81364 EUR |
| Revenue Per Share (Trailing Twelve Months) | 2.57799 EUR |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 EUR |
| Dividend Per Share (Trailing Twelve Months) | 0 EUR |
| Dividend Per Share (5 Year) | -99999.99 EUR |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -2.24 EUR |
| Excluding Extraordinary Items (Trailing Twelve Months) | -1.06475 EUR |
| Normalized (Last Fiscal Year) | -1.76671 EUR |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -2.24 EUR |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -1.06475 EUR |
| Including Extraordinary Items (Last Fiscal Year) | -2.24 EUR |
| Including Extraordinary Items (Trailing Twelve Months) | -1.06475 EUR |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.01734 EUR |
| Cash Per Share (Most Recent Quarter) | 0.70186 EUR |
| Cash Flow Per Share (Last Fiscal Year) | -2.24167 EUR |
| Cash Flow Per Share (Trailing Twelve Months) | -0.15732 EUR |
| Free Cash Flow Per Share (Trailing Twelve Months) | -99999.99 EUR |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -100,000 |
| Cash Flow Revenue (Trailing Twelve Months) | -100,000 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -22.03% |
| Pretax Margin (Last Fiscal Year) | -307.44% |
| Pretax Margin (5 Year) | -200.18% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 39.01% |
| Gross Margin (Trailing Twelve Months) | -99,999.99% |
| Gross Margin (5 Year) | -99,999.99% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -304.23% |
| Operating Margin (Trailing Twelve Months) | -22.55% |
| Operating Margin (5 Year) | -191.46% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -303.94% |
| Net Profit Margin (Trailing Twelve Months) | -22.43% |
| Net Profit Margin (5 Year) | -197.91% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 26.63% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -2.32% |
| Revenue Growth (3 Year) | -99,999.99% |
| Revenue Change (Trailing Twelve Months) | -99,999.99% |
| Revenue Per Share Growth | -99,999.99% |
| Revenue Growth (5 Year) | -10.83% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -215.97% |
| EPS Change (Trailing Twelve Months) | -99,999.99% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | 1 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -2,377,150 |
| Net Debt (Last Fiscal Year) | 3.6M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 8 |
| Price to Sales (Trailing Twelve Months) | 6 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 2 |
| Price to Book (Most Recent Quarter) | 0 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 18 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 0 |
| Quick Ratio (Most Recent Quarter) | -100,000 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 23 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -2,943,480 |
| Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -67 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 23 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -31.07% |
| Return on Assets (Trailing Twelve Months) | -3.61% |
| Return on Assets (5 Year) | -33.54% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -55.39% |
| Return on Equity (Trailing Twelve Months) | -4.11% |
| Return on Equity (5 Year) | -53.22% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -37.83% |
| Return on Investment (Trailing Twelve Months) | -3.63% |
| Return on Investment (5 Year) | -40.16% |